2,200 liver patients monitored to spot danger signs early
NCT ID NCT07438288
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 2,200 adults with liver cirrhosis to find factors that predict severe complications like liver failure or death. Researchers will review existing medical records without requiring extra visits or tests. The goal is to help doctors identify high-risk patients sooner and develop better prevention strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify which cirrhosis patients are at highest risk of serious complications, enabling earlier interventions.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, and results may take years to influence clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS AND CHRONIC LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Changi General Hospital
RECRUITINGSingapore, Singapore
-
Sengkang General Hospital
RECRUITINGSingapore, Singapore
-
Singapore General Hospital
RECRUITINGSingapore, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.